Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Galenica AG ( (CH:GALE) ) just unveiled an announcement.
At its 8th Annual General Meeting, Galenica AG’s shareholders approved all proposals, including a 4.5% dividend increase to CHF 2.30 per share and the election of Nadine Balkanyi-Nordmann to the Board of Directors. This reflects confidence in the company’s strategic direction and its position as a leading healthcare network in Switzerland. The meeting also saw the re-election of existing board members and approval of the compensation framework, indicating strong shareholder support for Galenica’s ongoing operations and governance.
More about Galenica AG
Galenica AG is a prominent player in the Swiss healthcare market, offering a wide range of services including pharmacies, pharmaceutical logistics, and home care. With approximately 8,000 employees, the company is dedicated to enhancing the health and well-being of people in Switzerland. It is listed on the Swiss Stock Exchange and is committed to shaping the future of healthcare with strong partnerships and a comprehensive network.
YTD Price Performance: 6.79%
Average Trading Volume: 104,368
Current Market Cap: CHF3.93B
For detailed information about GALE stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue